Abstract

There is a need for clinicians to emphasize "management" over "treatment" in their pharmacologic approach to schizophrenia. Using the term "treatment" may set up unrealistic expectations for a fuller recovery to a premorbid level of functioning, with potential use of overmedication and polypharmacy as well as possible unwanted adverse effects. The "management" concept allows clinicians to work with the best current medication practice, taking into account the wide variability in the course of illness and response to treatment. Prescribing clinicians should work collaboratively with other caregivers to enhance adaptive behavior and functional outcome through psychosocial rehabilitative interventions, within the context of recovery.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call